CeQur logo — Our mission is to simplify the lives of people with diabetes

CeQur

Our mission is to simplify the lives of people with diabetes

Founded 2008 Switzerland Horw, Switzerland 171 employees Series C Total: $271.60M Health Care, Medical Devices

General Information

Company Name CeQur
Founded Year 2008
Location Switzerland Horw, Switzerland
Employees 171
Industries Health Care, Medical Devices
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with CeQur. To contact CeQur, visit myceqursimplicity.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CeQur compare?

A PDF of CeQur and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CeQur soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

In The News Sep 24, 2026

Featured on Tech: Switzerland's top-funded tech companies in H1 2026

Regulatory Approval Sep 10, 2026

The CeQur Simplicity device is FDA cleared, enabling discreet and convenient mealtime insulin dosing.

Event Participation Sep 08, 2026

CeQur Simplicity was represented by Lindsey at the Indiana University School of Medicine Midwest Diabetes Update and Tech Course, where she connected with healthcare professionals.

About CeQur

CeQur, founded in 2008 and headquartered in Switzerland, is a healthcare startup with a mission to simplify the lives of people with diabetes. The company focuses on developing and commercializing simple drug delivery devices that seamlessly integrate into daily life. CeQur has developed a 3-day bolus insulin delivery device, CeQur Simplicity, which has received FDA clearance and CE marking. This revolutionary device allows for discreet insulin administration with just the click of two buttons, offering a convenient and inject-free solution. With its recent Series C investment of $115.00M in April 13, 2021, CeQur has garnered support from notable investors including Schroders, VI Partners, Endeavour Vision, GMS Capital, Tandem Diabetes Care, Kingdon Capital Management, Credit Suisse Entrepreneur Capital, Federated Kaufmann Fund, and Ypsomed. The company is currently in a pilot launch stage with the CeQur Simplicity device, while further broad availability is anticipated. CeQur’s commitment to simplifying insulin delivery is underscored by its successful clinical studies, which have demonstrated the device's safety, effectiveness, and high patient satisfaction levels compared to daily injections. The company's efforts to bring innovative technology to patients and aid compliance with insulin therapy present potential for significant impact within the healthcare industry.

Taxonomy: diabetes management, insulin delivery, wearable technology, FDA clearance, CE mark, patient satisfaction, compliance to therapy, pilot launch, clinical studies, innovative technology, Switzerland headquarters, Massachusetts operations

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $115.00M 9
Schroders, VI Partners +7
13 Apr 2021
Series C $100.00M 1
VI Partners
01 Sep 2015
Series B $27.00M -
09 Sep 2013
Series A $29.60M -
05 Jan 2010

CeQur Alternatives & Competitors

View All Alternatives
CeQur vs
Valeritas
Valeritas United States

Improving health and simplifying life for people with diabetes.

Venture round
35 employees
Biotechnology, Health Care
CeQur vs
Insulet Corporation
Insulet Corporation United States

Creating a better world through innovative technology that improves the lives of people with diabete...

Series E
3587 employees
Health Care, Medical Devices
CeQur vs

Empowering healthcare professionals with AI-driven diabetes care that ensures optimal treatment plan...

Grant
AI, Biotechnology

FAQ About CeQur

Our mission is to simplify the lives of people with diabetes
CeQur was founded in 2008.
CeQur is headquartered in Horw, Switzerland.
CeQur operates in Health Care and Medical Devices. Its work centres on diabetes management, insulin delivery, wearable technology and FDA clearance.
CeQur has approximately 171 employees.
CeQur has completed 4 funding rounds, raising a total of $271.60M. The latest funding stage is Series C.
Top alternatives and competitors to CeQur include Valeritas, Insulet Corporation, DreaMed Diabetes, Diatech Diabetes, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CeQur and Valeritas are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CeQur, https://bouncewatch.com/company/cequr, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes